Literature DB >> 26770554

Pyoderma gangrenosum of articulations carpi associated with ulcerative colitis: one case report.

Xia Meng1, Xinying Zhu1, Liping Chen2, Jing Wu1, Gaifang Liu1, Bing Xia2.   

Abstract

Pyoderma gangrenosum (PG), an extra-intestinal manifestation of ulcerative colitis (UC), is extremely rare. Up to now, there is no any data reported the occurrence of PG in joints, especially in China. The management of PG associated with UC is a therapeutic challenge. Our report here showed that a female patient diagnosed as UC complained a pustule in the dorsal side of left wrist, primarily was diagnosed as bone tuberculosis. The pustule progressed rapidly into a severe painful necrolytic cutaneous ulcer with a pale purple irregular destructive ulcer edge, this patient was diagnosed by UC complicated with PG, and skin lesions were cured by UC treatment. Here, we for the first time present a case acquired correct diagnosis and successful treatment of UC associated with PG of articulations carpi. We report this case here in order to provide more information about this disease to more doctors, furthermore, to decrease the rates of misdiagnosis and missed diagnosis.

Entities:  

Keywords:  Pyoderma gangrenosum; articulations carpi; infliximab; ulcerative colitis

Year:  2015        PMID: 26770554      PMCID: PMC4694454     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

1.  Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification.

Authors:  Angelo Valerio Marzano; Valentina Trevisan; Riccardo Lazzari; Carlo Crosti
Journal:  J Dermatolog Treat       Date:  2010-07-28       Impact factor: 3.359

2.  Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.

Authors:  Miho Ueda; Mayumi Katoh; Hideaki Tanizaki; Miki Tanioka; Yumi Matsumura; Yoshiki Miyachi
Journal:  Dermatol Online J       Date:  2012-01-15

3.  Bullous pyoderma gangrenosum associated with ulcerative colitis.

Authors:  Chandra Lal Naik; Gurcharan Singh; Lekshman Kumar; K Lokanatha
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Jan-Feb       Impact factor: 2.545

Review 4.  Pyoderma gangrenosum.

Authors:  J P Callen
Journal:  Lancet       Date:  1998-02-21       Impact factor: 79.321

Review 5.  Cutaneous manifestations of gastrointestinal disease: part II.

Authors:  Breck Thrash; Mahir Patel; Kejal R Shah; C Richard Boland; Alan Menter
Journal:  J Am Acad Dermatol       Date:  2013-02       Impact factor: 11.527

6.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

Review 7.  Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.

Authors:  Pascal Juillerat; Stephanie Christen-Zäch; François-Xavier Troillet; Suzanne Gallot-Lavallée; Renato G Pannizzon; Pierre Michetti
Journal:  Dermatology       Date:  2007       Impact factor: 5.366

8.  A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.

Authors:  G Andrisani; L Guidi; A Papa; A E Potenza; D Cervelli; A Armuzzi
Journal:  J Crohns Colitis       Date:  2012-08-11       Impact factor: 9.071

9.  Pyoderma gangrenosum and ulcerative colitis.

Authors:  J R Thornton; R H Teague; T S Low-Beer; A E Read
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

10.  Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.

Authors:  Yoram Menachem; Israel Gotsman
Journal:  Isr Med Assoc J       Date:  2004-02       Impact factor: 0.892

  10 in total
  2 in total

1.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

2.  Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis.

Authors:  Hyun Il Seo; Hyun-Ju Lee; Koon Hee Han
Journal:  Intest Res       Date:  2018-01-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.